DPT looking to pick up where Ben Venue leaves off; AMRI names new discovery chief;

> Texas CMO DPT said it's getting calls from Ben Venue customers in search of a new partner once the troubled plant goes under. Article

> AMRI ($AMRI) has appointed Charles River Laboratories ($CRL) veteran Michael Luther to serve as senior vice president of its discovery segment. More

> Catalent has inked a deal with Coster to supply its pressurized metered dose inhalers. News

> Yale University's in-house research organization is conducting a trial of Halozyme Therapeutics' ($HALO) recombinant human hyaluronidase in Type 1 diabetes patients with closed-loop insulin pumps. Item

Suggested Articles

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.